Genomic instability, DNA methylation, and natural selection in colorectal carcinogenesis

Seminars in Cancer Biology

Volumn 9, Issue 4, 1999, Pages 245-254

  Breivik, Jarle ^a   Gaudernack, Gustav ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Evolutionary mechanisms; Neoplastic transformation; Tumor progression

Indexed keywords

CARCINOGEN;

BASE MISPAIRING; COLON CARCINOGENESIS; COLORECTAL CANCER; DNA METHYLATION; GENETIC VARIABILITY; HUMAN; MICROSATELLITE INSTABILITY; MOLECULAR EVOLUTION; NATURAL SELECTION; REVIEW; SOMATIC CELL GENETICS;

EID: 0032876964     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1006/scbi.1999.0123     Document Type: Article

References (67)

1. Kinzler KW. The multistep nature of cancer. Trends Genet. 9:1993;138-141.
2. Bishop T, Karran P. Genetic steps in colorectal cancer. Nat Genet. 6:1994;217-219.
3. Adv Cancer Res. 72:1998;1-23.
4. Gaudernack G. Carcinogenesis and natural selection: A new perspective to the genetics and epigenetics of colorectal cancer. Adv Cancer Res, 1998.
5. Gustav Ficher, 1914.
6. Hum Genet. 51:1991;3075-3079.
7. Cell. 71:1992;543-546.
8. Vogelstein B. Cancer-susceptibility genes. Gatekeepers and caretakers. Nature. 386:1997;761-763.
9. Kinzler KW, Vogelstein B. Genetic instability in colorectal cancers. Nature. 386:1997;623-627.
10. Lothe RA. Microsatellite instability in human solid tumors. Mol Med Today. 3:1997;61-68.
11. Parsons R, Myeroff LL, Liu B, Willson JKV, Markowitz SD, Kinzler KW, Vogelstein B. Microsatellite instability and mutations of the transforming growth factor β type II receptor gene in colorectal cancer. Cancer Res. 55:1995;5548-5550.
12. Rampino N, Yamamoto H, Ionov Y, Li Y, Sawai H, Reed JC, Perucho M. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science. 275:1997;967-969.
13. Meuth M. Patterns of mutation in cancer cell. Cancer Surv. 28:1996;33-46.
14. Hiddemann W, Schumann J, Andreef M, Barlogie B, Herman CJ, Leif RC, Mayall BH, Murphy RF, Sandberg AA. Convention on nomenclature for DNA cytometry. Committee on Nomenclature, Society for Analytical Cytology. Cancer Genet Cytogenet. 13:1984;181-183.
15. Thompson, JS, Thompson, MW, 1998.
16. Chahill DP, Lengauer C, Yu J, Riggins GJ, Willson JKV, Markowitz SD, Kinzler KW, Vogelstein B. Mutations of mitotic checkpoint genes in human cancers. Nature. 392:1998;300-303.
17. Meling GI, Lothe RA, Børresen AL, Graue C, Hauge S, Clausen OP, Rognum TO. The TP53 tumour suppressor gene in colorectal carcinomas. II. Relation to DNA ploidy pattern and clinicopathological variables. Br J Cancer. 67:1993;93-98.
18. Tsujimoto H, Sugihara H, Hagiwara A, Hattori T. Amplification of growth factor receptor genes and DNA ploidy pattern in the progression of gastric cancer. Virchows Arch. 431:1997;383-389.
19. Darwin CR. On the Origin of Species by Means of Natural Selection, 1859;Murray, London.
20. Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson JD. Molecular Biology of the Cell, 3rd edn. 1994;Garland Publishing, Inc., New York.
21. Dawkins R. The Selfish Gene, 2nd edn. 1989;Oxford University Press, Oxford.
22. Tomlinson IP, Novelli MR, Bodmer WF. The mutation rate and cancer. Proc Natl Acad Sci U S A. 93:1996;14800-14803.
23. Davis BK. The forces driving molecular evolution. Prog Biophys Mol Biol. 69:1998;83-150.
24. Bartsch H, Spiegelhalder B. Environmental exposure to N-nitroso compounds (NNOC) and precursors: an overview. Eur J Cancer Prev 5 Suppl. 1:1996;11-17.
25. Kawate H, Sakumi K, Tsuzuki T, Nakatsuru Y, Ishikawa T, Takahashi S, Takano H, Noda T, Sekiguchi M. Separation of killing and tumorigenic effects of an alkylating agent in mice defective in two of the DNA repair genes. Proc Natl Acad Sci U S A. 95:1998;5116-5120.
26. Karran P, Hampson R. Genomic instability and tolerance to alkylating agents. Cancer Surv. 28:1996;69-85.
27. Aquilina G, Fiumicino S, Zijno A, Martinelli S, Overkamp WJ, Zdzienicka MZ, Oshimura M, Wild CP, Bignami M. Reversal of methylation tolerance by transfer of human chromosome 2. Mutat Res. 385:1997;115-126.
28. Karran P, Bignami M. DNA damage tolerance, mismatch repair and genome instability. Bioessays. 16:1994;833-839.
29. Lawley PD. From fluorescence spectra to mutational spectra, a historical overview of DNA-reactive compounds. IARC Sci Publ. 1994;3-22.
30. 6-substituted guanine-induced mutagenesis of ras oncogenes. Carcinogen. 86:1989;8650-8654.
31. Sancar A. Excision repair in mammalian cells. J Biol Chem. 270:1995;15915-15918.
32. Bohr VA. DNA repair fine structure and its relations to genomic instability. Carcinogen. 16:1995;2885-2892.
33. Ramsahoye BH, Davies CS, Mills KI. DNA methylation: biology and significance. Blood Rev. 10:1996;249-261.
34. Monk M. Epigenetic programming of differential gene expression in development and evolution. Dev Genet. 17:1995;188-197.
35. Feil R, Kelsey G. Genomic imprinting: a chromatin connection. Am J Hum Genet. 61:1997;1213-1219.
36. Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JP. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res. 72:1998;141-196.
37. Zingg JM, Jones PA. Genetic and epigenetic aspects of DNA methylation on genome expression, evolution, mutation and carcinogenesis. Carcinogen. 18:1997;869-882.
38. Slattery ML, Schaffer D, Edwards SL, Ma KN, Potter JD. Are dietary factors involved in DNA methylation associated with colon cancer? Nutr Cancer. 28:1997;52-62.
39. Chuang LS, Ian HI, Koh TW, Ng HH, Xu G, Li BF. Human DNA-(cytosine-5) methyltransferase-PCNA complex as a target for p21WAF1. Science. 277:1997;1996-2000.
40. Van den Wyngaert I, Sprengel J, Kass SU, Luyten WH. Cloning and analysis of a novel human putative DNA methyltransferase. FEBS Letters. 426:1998;283-289.
41. Okano M, Xie S, Li E. Dnmt2 is not required for de novo and maintenance methylation of viral DNA in embryonic stem cells. Nucleic Acids Res. 26:1998;2536-2540.
42. Baylin SB. Tying it all together: epigenetics, genetics, cell cycle, and cancer. Science. 277:1997;1948-1949.
43. Denissenko MF, Chen JX, Tang MS, Pfeifer GP. Cytosine methylation determines hot spots of DNA damage in the human p53 gene. Proc Natl Acad Sci USA. 94:1997;3893-3898.
44. Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, Baylin SB. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet. 7:1994;536-540.
45. Issa JP, Vertino PM, Boehm CD, Newsham IF, Baylin SB. Switch from monoallelic to biallelic human IGF2 promoter methylation during aging and carcinogenesis. Proc Natl Acad Sci U S A. 93:1996;11757-11762.
46. Anonymous. Folate, alcohol, methionine, and colon cancer risk: is there a unifying theme? Nutr Rev. 52:1994;18-20.
47. Halsted CH, Villanueva J, Chandler CJ, Stabler SP, Allen RH, Muskhelishvili L, James SJ, Poirier L. Ethanol feeding of micropigs alters methionine metabolism and increases hepatocellular apoptosis and proliferation. Hepatology. 23:1996;497-505.
48. Counts JL, Goodman JI. Hypomethylation of DNA: a possible epigen etic mechanism involved in tumor promotion. Prog Clin Biol Res. 391:1995;81-101.
49. Wainfan E, Poirier LA. Methyl groups in carcinogenesis: effects on DNA methylation and gene expression. Hum Genet. 52:1992;2071.
50. Giovannucci E, Stampfer MJ, Colditz GA, Rimm EB, Trichopoulos D, Rosner BA, Speizer FE, Willett WC. Folate, methionine, and alcohol intake and risk of colorectal adenoma. J Natl Cancer Inst. 85:1993;875-884.
51. Christman JK, Sheikhnejad G, Dizik M, Abileah S, Wainfan E. Reversibility of changes in nucleic acid methylation and gene expression induced in rat liver by severe dietary methyl deficiency. Carcinogen. 14:1993;551-557.
52. Laird PW, Jackson-Grusby L, Fazeli A, Dickinson SL, Jung WE, Li E, Weinberg RA, Jaenisch R. Suppression of intestinal neoplasia by DNA hypomethylation. Cell. 81:1995;197-205.
53. Ahuja N, Mohan AL, Li Q, Stolker JM, Herman JG, Hamilton SR, Baylin, S B, Issa JP. Association between CpG island methylation and microsatellite instability in colorectal cancer. Hum Genet. 57:1997;3370-3374.
54. Lengauer C, Kinzler KW, Vogelstein B. DNA methylation and genetic instability in colorectal cancer cells. Proc Natl Acad Sci U S A. 94:1997;2545-2550.
55. 6-methylguanine-DNA methyltransferase gene. Hum Genet. 57:1997;3672-3677.
56. Cunningham JM, Christensen ER, Tester DJ, Kim CY, Roche PC, Burgart LJ, Thibodeau SN. Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Hum Genet. 58:1998;3455-3460.
57. Kane MF, Loda M, Gaida GM, Lipman J, Mishra R, Goldman H, Jessup JM, Kolodner R. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Hum Genet. 57:1997;808-811.
58. Chen RZ, Pettersson U, Beard C, Jackson-Grusby L, Jaenisch R. DNA hypomethylation leads to elevated mutation rates. Nature. 395:1998;89-93.
59. Kim YI, Pogribny IP, Basnakian AG, Miller JW, Selhub J, James SJ, Mason JB. Folate deficiency in rats induces DNA strand breaks and hypomethylation within the p53 tumor suppressor gene. Am J Clin Nutr. 65:1997;46-52.
60. Yoder JA, Walsh CP, Bestor TH. Cytosine methylation and the ecology of intragenomic parasites. Trends Genet. 13:1997;335-340.
61. Bender J. Cytosine methylation of repeated sequences in eukaryotes: the role of DNA pairing. Trends Biochem Sci. 23:1998;252-256.
62. Darwin CR, Wallace AR. On the tendency of species to form variet ies; and on the perpetuation of varieties and species by natural means of selection. J Proc Linn Soc, Zoology. 2:1858;45-62.
63. Demetrius L. Directionality principles in thermodynamics and e volution. Proc Natl Acad Sci USA. 94:1997;3491-3498.
64. Robey E, Fowlkes BJ. Selective events in T cell development. A nnu Rev Immunol. 12:1994;675-705.
65. Klein CB, Costa M. DNA methylation, heterochromatin and epigenetic carcinogens. Mutat Res. 386:1997;163-180.
66. Rosenberg SM. Mutation for survival. Curr Opin Genet Dev. 7:1997;829-834.
67. Krakauer DC, Zanotto PM, Pagel M. Prion's progress: patterns and rates of molecular evolution in relation to spongiform disease. J Mol Evol. 47:1998;133-145.